Anna E Coghill
Overview
Explore the profile of Anna E Coghill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
1281
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coghill A, Van Bibber N, Baiocchi R, Arnold S, Riedlinger G, Schneider B, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Feb;
PMID: 40019488
Background: People living with HIV (PWH) have improved life expectancy due to effective HIV therapy but still experience immune impairment (e.g., altered CD4/CD8 T-cells). We hypothesized that tumors diagnosed in...
2.
Jackson S, Francis J, Pfeiffer R, Proietti C, Coghill A, Yu K, et al.
J Infect Dis
. 2025 Feb;
PMID: 39932888
We investigated anti-EBV IgA and IgG responses by sex among 387 cancer-free individuals in Asia. Antibody responses were measured using an EBV proteome array to assess age-adjusted sex-specific associations with...
3.
Islam J, Guo Y, Turner K, Tabriz A, Lin Y, Vidot D, et al.
JNCI Cancer Spectr
. 2024 Nov;
9(2).
PMID: 39579085
Background: People with HIV diagnosed with stage IV cancer are less likely to receive palliative care compared with those without HIV. Our objective was to evaluate inequities in palliative care...
4.
Chen Y, Shin Y, Spillane S, Shiels M, Coghill A, Enewold L, et al.
Cancer Med
. 2024 Oct;
13(20):e70211.
PMID: 39444260
Background: Understanding factors associated with opioid dispensing in cancer patients is important for developing tailored guidelines and ensuring equitable access to pain management. We examined patterns and predictors of opioid...
5.
Liu K, Hsu W, Bu W, Yu K, Wang C, Chien Y, et al.
Open Forum Infect Dis
. 2024 Sep;
11(9):ofae464.
PMID: 39229285
Elevated levels of Epstein-Barr virus (EBV) gp350 and gH/gL antibodies have been associated with a lower risk of developing nasopharyngeal carcinoma (NPC), although the evidence remains inconclusive and unexplained. We...
6.
Sarathkumara Y, Van Bibber N, Liu Z, Heslop H, Rouce R, Coghill A, et al.
bioRxiv
. 2024 Aug;
PMID: 39211169
Epstein-Barr virus (EBV) is associated with a diverse range of lymphomas. EBV-specific T-cell (EBVST) immunotherapies have shown promise in safety and clinical effectiveness in treating EBV-associated lymphomas, but not all...
7.
Sarathkumara Y, Xian R, Liu Z, Yu K, Chan J, Kwong Y, et al.
Int J Cancer
. 2024 Jul;
155(8):1476-1486.
PMID: 38995124
Epstein-Barr virus (EBV) is an oncogenic virus associated with various malignancies, including classical Hodgkin lymphoma (cHL). Despite its known association, the specific role of humoral immune response to EBV remains...
8.
Gillis N, Dickey B, Colin-Leitzinger C, Tang Y, Putney R, Mesa T, et al.
J Infect Dis
. 2024 Apr;
230(3):680-688.
PMID: 38657098
Background: Cancer-related deaths for people with human immunodeficiency virus (PWH) are increasing due to longer life expectancies and disparately poor cancer-related outcomes. We hypothesize that advanced biological aging contributes to...
9.
Mandishora R, Galati L, Reich R, Combes J, McKay-Chopin S, Makunike-Mutasa R, et al.
Open Forum Infect Dis
. 2024 Apr;
11(4):ofae165.
PMID: 38623569
Incidence of conjunctival squamous cell carcinoma (cSCC) in Zimbabwe is >30-fold higher than the global average. cSCC risk is notably higher among people with human immunodeficiency virus, implicating impaired immune...
10.
Suk-Ouichai C, Coghill A, Schabath M, Sanchez J, Chahoud J, Necchi A, et al.
Nat Rev Urol
. 2024 Jan;
21(6):373-383.
PMID: 38238527
The number of people living with HIV infection has been increasing globally. Administration of antiretroviral therapy is effective in controlling the infection for most patients and, as a consequence, people...